Trump’s ‘cure’ drugmaker seeks emergency approval

Last Updated on 3 months by News Admin

Regeneron has asked the US authorities for emergency approval of the experimental drug cocktail that President Donald Trump praised during his Covid-19 treatment.

The combination of antibodies made by Reeneron mimic our own immune response. The antibodies physically stick to the coronavirus so they cannot get inside the body’s cells and they make the virus more “visible” to the rest of the immune system.

Trump said the cocktail was a cure rather than a therapeutic measure, and promised to provide it free of charge.

In a statement, the drugmaker said that if an Emergency Use Authorisation (EUA) was granted, access to the treatment would initially be limited to about 50,000 patients.

“We expect to have doses available for 300,000 patients in total within the next few months,” the company said.

Recommended For You

About the Author: News Admin

NEWS784 was founded in November 2015. We welcome press releases, photos, news tips and story ideas. Contact: WhatsApp: 496 2450